Global Artificial Corneal Implants Market is valued at approximately USD 42.01 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.1% over the forecast period 2022-2029. Artificial corneal implantation is a term that is generally used to refer to patients who are living corneal transplants from a human donor to restore their vision. Factors such as rapid growth in the geriatric population, surging demand for corneal transplants, coupled with the dearth of human corneas are the key factors that are fueling the demand for artificial corneal implants in the global market.

In addition, the rising incidences of eye disorders including corneal stromal dystrophies, ocular cicatricial pemphigoid, keratoconus, and infectious keratitis is further stipulating the market growth across the globe. Globally, 10 million individuals are affected with corneal blindness, which is the third most common cause of blindness after glaucoma and cataracts. The Eye Bank Association of America reported in a research piece from 2021 that 200,000 corneal implant surgeries are likely to be carried out annually. Furthermore, according to a Harvard Medical School paper, nearly 12.7 million people worldwide are reported that only 1 in every 70 persons in need of a transplant is treated. To address the lack of donor tissue and the issues with corneal donor transplantation, significant efforts have been undertaken to develop substitutes for human donor corneas. Therefore, these factors have increased the use of artificial corneal implants worldwide. Furthermore, increased expansion of the healthcare sector by governments and rising R&D investment for product developments are leveraging various opportunities over the anticipated years. However, the shortage of ophthalmologists and some complications are associated with post-surgery stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Artificial Corneal Implants Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the favorable reimbursement scenario, availability of technologically advanced products, and growing R&D activities. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising disposable income, increasing awareness regarding ocular disorders, as well as the presence of manufacturers in the regional market.

Major market players included in this report are:
FCI Ophthalmics, Inc.
Beijing Microkpro Medical Instrument Co. Ltd.
DIOPTEX Medizinprodukte Forschungs
KeraMed, Inc.
EyeYon
Presbia plc
San Diego Eye Bank
CorneaGen
AJL Ophthalmic
LinkoCare Life Sciences AB

Recent Developments in the Market:
? In June 2021, EyeYon obtained the CE Mark for its EndoArt, the globe’s first and only synthetic implant that substitutes the human endothelium, which is not regenerated by the human body, after clinical trials demonstrated its safety and efficacy for treating chronic corneal edoema.


Global Artificial Corneal Implants Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Transplant Type, Indication, Type of Implant, End-Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Transplant Type:
Hard Keratoprosthesis
Soft Keratoprsothesis
By Indication:
Stevens-Johnson Syndrome (SJS)
Ocular Cicatricial Pemphigoid (OCP)
Ocular Burns
Keratoconus
Corneal Stromal Dystrophies
Others
By Type of Implant:
Synthetic
Biosynthetic
By End-Use:
Hospitals
Ophthalmic Centers
Ambulatory Surgical Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World